Merck Halts Sale Of Niacin Drug In 40 Countries | WAMU 88.5 - American University Radio

NPR : News

Filed Under:

Merck Halts Sale Of Niacin Drug In 40 Countries

Drugmaker Merck just stuck a fork in a vitamin-based drug to prevent heart disease and stroke.

The company is withdrawing Tredaptive, a long-acting pill combining niacin (No. 3 in the long list of B vitamins) and laropiprant, a chemical that reduces the unpleasant skin flushing caused by high doses of niacin.

Tredaptive was never approved in the U.S. — the Food and Drug Administration rejected the drug under another name in 2008. But now Merck is taking the medicine off the market in 40 countries where it has been sold. The company also told doctors to stop prescribing it.

Merck said in December that a big study found the drug didn't work. What's more, people taking it had more serious side effects than those who got a placebo. People in both groups also got simvastatin (sold under the brand-name Zocor) to lower their bad cholesterol, or LDL.

Tredaptive seemed like a great idea — on paper.

Niacin is one of the few ways to boost good cholesterol, or HDL. People whose HDL is too low are at a higher risk of having heart attacks and strokes, even when their LDL is right where it ought to be.

Many people who take niacin for this reason can't tolerate it, though. So a drug that had the good effects of niacin without the discomfort looked appealing.

The failure of Tredaptive has cast a pall on the whole idea that raising HDL with a drug can help patients avoid heart attacks and strokes.

Cleveland Clinic cardiologist Steven Nissen told Shots last month that he wasn't willing to ditch the idea that boosting HDL would reduce heart disease. Nevertheless, he said then, the failure of Tredaptive represented "a serious blow to the theory."

Merck's withdrawal of the drug won't put a dent in the fortunes of the company. Global sales amounted to a puny $13 million for the three quarters that ended last September.

Copyright 2013 National Public Radio. To see more, visit http://www.npr.org/.

NPR

The Exquisite Dissonance Of Kehinde Wiley

The Brooklyn Museum's mid-career Wiley retrospective wraps up this week; his large, elaborate works depict black men and women in traditional forms like oil, bronze sculture and even stained glass.
NPR

In New Jersey, A Beef Over Pork Roll Sparks Rival Festivals

What is pork roll? As one fan puts it, "It's like Spam meets bacon." And this Saturday, Trenton, N.J., will host not one, but two competing festivals devoted to this Garden State meat delicacy.
NPR

Senate Blocks Bill To End Government Collection Of Phone Records

The Senate worked late into the night but failed to agree on extending government surveillance programs under the USA Patriot Act before adjourning for the Memorial Day holiday.
NPR

The Future Of Cardiology Will Be Shown In 3-D

The Living Heart Project aims to create a detailed simulation of the human heart that doctors and engineers can use to test experimental treatments and interventions.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.